Page last updated: 2024-11-05

tyramine and Disease Models, Animal

tyramine has been researched along with Disease Models, Animal in 42 studies

Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.

Research Excerpts

ExcerptRelevanceReference
"To test the hypothesis that sympathetic stimulation with tyramine initiates atrial fibrillation (AF) by early after depolarization (EAD)-mediated triggered activity at the left atrial PV (LAPV) junction."7.78Spontaneous atrial fibrillation initiated by tyramine in canine atria with increased sympathetic nerve sprouting. ( Chen, PS; Fishbein, MC; Karagueuzian, HS; Lin, SF; Mandel, WJ; Miyauchi, Y; Numata, A; Ono, N; Weiss, JN, 2012)
"The objective of the present investigation was to determine whether or not tyramine induces coma in experimental animals with impaired mitochondrial monoamine oxidase function, and whether the coma in these animals was a function of increased cerebrospinal fluid (CSF) pressure."7.66Similarity between tyramine-induced neurotoxicity and the coma of Reye's syndrome. ( Ali, FM; Camp, VM; Caplan, DB; Faraj, BA; Malveaux, EJ, 1983)
"Corticosterone treatment altered all parameters in behavioral tests, leading to a depressive- and anxious-like behavior."5.51Reversal effect of Riparin IV in depression and anxiety caused by corticosterone chronic administration in mice. ( Barbosa Filho, JM; Capibaribe, VCC; Chaves, RC; da Silva, DMA; de Carvalho, AMR; de Sousa, FCF; Gutierrez, SJC; Lopes, IS; Macêdo, DS; Mallmann, ASV; Oliveira, ICM; Oliveira, NF; Valentim, JT; Vasconcelos, SMM, 2019)
" This study aimed to investigate the activity of RIP II in a corticosterone-induced depression mice model."3.88Riparin II ameliorates corticosterone-induced depressive-like behavior in mice: Role of antioxidant and neurotrophic mechanisms. ( Barbosa Filho, JM; Capibaribe, VCC; Chaves, RC; da Silva, DMA; de Araújo, MA; de Sousa, FCF; de Souza, AG; Gutierrez, SJC; Lopes, IS; Macêdo, DS; Oliveira, ICM; Valentim, JT, 2018)
"To test the hypothesis that sympathetic stimulation with tyramine initiates atrial fibrillation (AF) by early after depolarization (EAD)-mediated triggered activity at the left atrial PV (LAPV) junction."3.78Spontaneous atrial fibrillation initiated by tyramine in canine atria with increased sympathetic nerve sprouting. ( Chen, PS; Fishbein, MC; Karagueuzian, HS; Lin, SF; Mandel, WJ; Miyauchi, Y; Numata, A; Ono, N; Weiss, JN, 2012)
"The present study examined the antinociceptive effects of (O-methyl) N-benzoyl-tyramine (riparin I, ripI) isolated from the unripe fruit of Aniba riparia in chemical and thermal behavioral models of pain, such as acetic acid-induced abdominal writhing, formalin, and hot-plate tests in mice."3.75Antinociceptive effects of (O-methyl)-N-benzoyl tyramine (riparin I) from Aniba riparia (Nees) Mez (Lauraceae) in mice. ( Amaral, JF; Araújo, FL; Barbosa-Filho, JM; de Sousa, FC; Gutierrez, SJ; Leite, CP; Melo, CT; Moura, BA; Rocha, NF; Vasconcelos, SM; Viana, GS, 2009)
"The objective of the present investigation was to determine whether or not tyramine induces coma in experimental animals with impaired mitochondrial monoamine oxidase function, and whether the coma in these animals was a function of increased cerebrospinal fluid (CSF) pressure."3.66Similarity between tyramine-induced neurotoxicity and the coma of Reye's syndrome. ( Ali, FM; Camp, VM; Caplan, DB; Faraj, BA; Malveaux, EJ, 1983)
"Corticosterone treatment altered all parameters in behavioral tests, leading to a depressive- and anxious-like behavior."1.51Reversal effect of Riparin IV in depression and anxiety caused by corticosterone chronic administration in mice. ( Barbosa Filho, JM; Capibaribe, VCC; Chaves, RC; da Silva, DMA; de Carvalho, AMR; de Sousa, FCF; Gutierrez, SJC; Lopes, IS; Macêdo, DS; Mallmann, ASV; Oliveira, ICM; Oliveira, NF; Valentim, JT; Vasconcelos, SMM, 2019)
"Dissociating glucocorticoid receptor (GR) ligands hold great promise for treating inflammatory disorders since it is assumed that they exert beneficial activities mediated by transrepression but avoid adverse effects of GR action requiring transactivation."1.35Therapeutic and adverse effects of a non-steroidal glucocorticoid receptor ligand in a mouse model of multiple sclerosis. ( Hanisch, UK; John, M; Lühder, F; Menzfeld, C; Reichardt, HM; Tischner, D; Tuckermann, JP; van den Brandt, J; Wüst, S, 2009)
" This was achieved by using fluorescence in situ hybridization combined with tyramide signal amplification (FISH-TSA) and an 8."1.31Detection of integrated murine leukemia viruses in a mouse model of acute myeloid leukemia by fluorescence in situ hybridization combined with tyramide signal amplification. ( Acar, H; Copeland, NG; Gilbert, DJ; Jenkins, NA; Largaespada, DA, 2000)
"The tachycardia was abolished by treatment with the beta-antagonist propranolol, demonstrating that it was mediated by catecholamines acting on cardiac beta-receptors."1.31Animal model of neuropathic tachycardia syndrome. ( Appalsamy, M; Carson, RP; Davis, TL; Diedrich, A; Robertson, D, 2001)
"Treatment with nimodipine (20 mg kg-1) from week 6 onwards significantly increased the sciatic nerve blood flow as compared to placebo-treated diabetic BB/Wor rats."1.29Beneficial effect of the Ca2+ antagonist, nimodipine, on existing diabetic neuropathy in the BB/Wor rat. ( Biessels, G; Bravenboer, B; de Wildt, DJ; Gispen, WH; Kappelle, AC; Traber, J; van Buren, T, 1994)

Research

Studies (42)

TimeframeStudies, this research(%)All Research%
pre-19907 (16.67)18.7374
1990's6 (14.29)18.2507
2000's10 (23.81)29.6817
2010's11 (26.19)24.3611
2020's8 (19.05)2.80

Authors

AuthorsStudies
Wolinsky, TD1
Swanson, CJ1
Smith, KE1
Zhong, H1
Borowsky, B1
Seeman, P1
Branchek, T1
Gerald, CP1
Solinski, HJ1
Dranchak, P1
Oliphant, E1
Gu, X1
Earnest, TW1
Braisted, J1
Inglese, J1
Hoon, MA1
Abrams, RPM1
Yasgar, A2
Teramoto, T1
Lee, MH1
Dorjsuren, D1
Eastman, RT1
Malik, N1
Zakharov, AV1
Li, W1
Bachani, M1
Brimacombe, K1
Steiner, JP1
Hall, MD2
Balasubramanian, A1
Jadhav, A2
Padmanabhan, R1
Simeonov, A2
Nath, A1
Yang, W1
Liu, H2
Xu, L1
Yu, T1
Zhao, X2
Yao, S1
Zhao, Q1
Barnes, S1
Cohn, SM1
Dann, SM1
Zhang, H3
Zuo, X1
Li, Y2
Cong, Y1
Xu, Z2
Zhang, Q1
Ding, C1
Wen, F1
Sun, F1
Liu, Y2
Tao, C1
Yao, J1
Gao, Q1
Tang, S1
Chen, H3
Li, X1
Jiang, Y1
Fu, S1
Lin, S1
Wang, Q1
Cui, Y1
Wu, X1
Wang, J1
Mallmann, ASV2
Chaves, RC3
de Oliveira, NF1
Oliveira, ICM3
Capibaribe, VCC3
Valentim, JT3
da Silva, DMA3
Sartori, DP1
Rodrigues, GC1
Filho, AJMC1
Riello, GB1
Fonteles, MMF1
Vasconcelos, SMM2
Macedo, D1
Gutierrez, SJC3
Filho, JMB1
de Carvalho, AMR2
de Sousa, FCF3
Zagefka, H1
Huynh, HP1
Senger, AR1
Derington, CG1
Colantonio, LD1
Herrick, JS1
Cook, J1
King, JB1
Rosenson, RS1
Poudel, B1
Monda, KL1
Navar, AM1
Mues, KE1
Stevens, VW1
Nelson, RE1
Vanneman, ME1
Muntner, P1
Bress, AP1
Ma, B1
Ren, G1
Xu, J1
Yin, C1
Shi, Y1
Rahsepar, AA1
Bluemke, DA1
Habibi, M1
Liu, K1
Kawel-Boehm, N1
Ambale-Venkatesh, B1
Fernandes, VRS1
Rosen, BD1
Lima, JAC1
Carr, JC1
Freitag, TM1
Chen-Sankey, JC1
Duarte, DA1
Ramsey, MW1
Choi, K1
Winkler-Heil, R1
Hussain, M1
Hofmann, W1
Nicotera, AG1
Dicanio, D1
Pironti, E1
Bonsignore, M1
Cafeo, A1
Efthymiou, S1
Mondello, P1
Salpietro, V1
Houlden, H1
Di Rosa, G1
Hayes-Ryan, D1
O'Donoghue, K1
McCarthy, C1
Totorika, A1
Meaney, S1
Pang, RD1
Dormanesh, A1
Hoang, Y1
Chu, M1
Allem, JP1
Girón-Ortega, JA1
Márquez-Coello, M1
Gutiérrez-Saborido, D1
Arizcorreta, A1
Cuesta-Sancho, S1
Girón-González, JA1
Dovrat, G1
Pevzner, S1
Berthon, C1
Lerner, A1
Maimon, E1
Vainer, R1
Karpasas, M1
Ben-Elyiahu, Y1
Moisy, P1
Bettelheim, A1
Zilbermann, I1
Vanden Broeck, SMP1
Nelson, DJ1
Collado, A1
Falivene, L1
Cavallo, L1
Cordes, DB1
Slawin, AMZ1
Van Hecke, K1
Nahra, F1
Cazin, CSJ1
Nolan, SP1
Kranidiotis-Hisatomi, N1
Yi, H1
Oestreich, M1
Kwiezinski, C1
Weller, C1
van Pinxteren, D1
Brüggemann, M1
Mertes, S1
Stratmann, F1
Herrmann, H1
Treggiari, D1
Tridello, G1
Menin, L1
Borruso, A1
Pintani, E1
Iansa, P1
Cipolli, M1
Melotti, P1
Ren, L1
Liu, L3
Shu, X1
Lin, W1
Yang, P1
Chen, J1
Teo, KL1
Xiao, F1
Wang, H1
Yao, T1
Yang, X1
Yu, DYW1
Rogach, AL1
Bordet, A1
Leitner, W1
Gao, S1
Xia, F1
Li, B2
Abdul Razak, IB1
Lu, K1
Brown, DE1
Wang, R1
Cheng, Y1
Ni, S1
Qu, H1
Xing, H1
Zhu, X1
Yuan, M1
Wang, L1
Yu, J1
Yang, L1
Cao, L1
Zhang, S1
Zhao, D1
Yan, T1
Yang, G1
Lin, Z1
Luo, M1
Ye, N1
Lee, SW1
Carnicelli, J1
Getya, D1
Gitsov, I1
Phillips, KS1
Ren, D1
Grützmacher, PG1
Suarez, S1
Tolosa, A1
Gachot, C1
Song, G1
Wang, B1
Presser, V1
Mücklich, F1
Anasori, B1
Rosenkranz, A1
Demireva, M1
Armentrout, PB1
Feng, D1
Cao, K1
He, ZZ1
Knibbs, LD1
Jalaludin, B1
Leskinen, A1
Roponen, M1
Komppula, M1
Jalava, P1
Guo, PY1
Xu, SL1
Yang, BY1
Hu, L1
Zeng, XW1
Chen, G1
Yu, HY1
Lin, L1
Dong, G1
Machulkin, AE1
Shafikov, RR1
Uspenskaya, AA1
Petrov, SA1
Ber, AP1
Skvortsov, DA1
Nimenko, EA1
Zyk, NU1
Smirnova, GB1
Pokrovsky, VS1
Abakumov, MA1
Saltykova, IV1
Akhmirov, RT1
Garanina, AS1
Polshakov, VI1
Saveliev, OY1
Ivanenkov, YA1
Aladinskaya, AV1
Finko, AV1
Yamansarov, EU1
Krasnovskaya, OO1
Erofeev, AS1
Gorelkin, PV1
Dontsova, OA1
Beloglazkina, EK1
Zyk, NV1
Khazanova, ES1
Majouga, AG1
Zheng, YK1
Su, BJ1
Wang, YQ1
Wang, HS1
Liao, HB1
Liang, D1
Shataer, D1
Li, J1
Duan, XM1
Xin, XL1
Aisa, HA1
Allu, SR1
Ravotto, L1
Troxler, T1
Vinogradov, SA1
Cheruku, RR1
Tracy, EC1
Tabaczynski, W1
Missert, JR1
Baumann, H1
Pandey, RK1
Rohde, JM1
Karavadhi, S1
Pragani, R1
Fang, Y1
Zhang, W1
McIver, A1
Zheng, H1
Liu, Q1
Davis, MI1
Urban, DJ1
Lee, TD1
Cheff, DM1
Hollingshead, M1
Henderson, MJ1
Martinez, NJ1
Brimacombe, KR1
Zhao, W1
Klumpp-Thomas, C1
Michael, S1
Covey, J1
Moore, WJ1
Stott, GM1
Li, Z1
Frye, S1
Shen, M1
Wang, X1
Patnaik, S1
Boxer, MB1
Cheng, C1
Huang, B1
Chen, R1
Huang, Y1
Pei, W1
Katahara, S1
Sugiyama, Y1
Yamane, M1
Komiya, Y1
Sato, T1
Chida, N1
Wang, W1
Voss, KM1
Liu, J1
Gordeev, MF1
Rodrigues de Carvalho, AM1
Vasconcelos, LF2
Moura Rocha, NF1
Vasconcelos Rios, ER1
Dias, ML2
Maria de França Fonteles, M1
Gaspar, DM1
Barbosa Filho, JM3
Chavez Gutierrez, SJ1
Florenço de Sousa, FC1
Lopes, IS2
de Souza, AG1
de Araújo, MA1
Macêdo, DS2
Oliveira, NF1
Huynh, T1
Uaesoontrachoon, K1
Quinn, JL1
Tatem, KS1
Heier, CR1
Van Der Meulen, JH1
Yu, Q1
Harris, M1
Nolan, CJ1
Haegeman, G3
Grounds, MD1
Nagaraju, K1
de Carvalho, AM1
Rocha, NF2
Rios, ER1
Silva, MI1
de França Fonteles, MM1
Filho, JM1
Gutierrez, SJ2
de Sousa, FC2
Rauner, M1
Thiele, S1
Sinningen, K1
Winzer, M1
Salbach-Hirsch, J1
Gloe, I1
Peschke, K1
Tuckermann, JP2
Hofbauer, LC1
Amaro, CA1
González-Cortazar, M1
Herrera-Ruiz, M1
Román-Ramos, R1
Aguilar-Santamaría, L1
Tortoriello, J1
Jiménez-Ferrer, E1
Hoover, DB1
Ozment, TR1
Wondergem, R1
Li, C1
Williams, DL1
Araújo, FL1
Melo, CT1
Moura, BA1
Leite, CP1
Amaral, JF1
Barbosa-Filho, JM1
Vasconcelos, SM1
Viana, GS1
Wüst, S1
Tischner, D1
John, M1
Menzfeld, C1
Hanisch, UK1
van den Brandt, J1
Lühder, F1
Reichardt, HM1
Numata, A1
Miyauchi, Y1
Ono, N1
Fishbein, MC1
Mandel, WJ1
Lin, SF1
Weiss, JN1
Chen, PS1
Karagueuzian, HS1
Reber, LL1
Daubeuf, F1
Plantinga, M1
De Cauwer, L1
Gerlo, S1
Waelput, W1
Van Calenbergh, S1
Tavernier, J1
Lambrecht, BN1
Frossard, N1
De Bosscher, K1
Aubin, N1
Barneoud, P1
Carter, C1
Caille, D1
Sontag, N1
Marc, C1
Lolivier, J1
Gardes, A1
Perron, C1
Le Kim, A1
Charieras, T1
Pandini, M1
Burnier, P1
Puech, F1
Jegham, S1
George, P1
Scatton, B1
Curet, O1
Parrish, DC1
Gritman, K1
Van Winkle, DM1
Woodward, WR1
Bader, M1
Habecker, BA1
Kluger, J1
Horner, H1
Reidenberg, MM1
Faraj, BA1
Caplan, DB1
Malveaux, EJ1
Camp, VM1
Ali, FM1
Orikasa, S1
Kisara, K1
Kaysen, GA1
Hoye, E1
Jones, H1
Kappelle, AC1
Biessels, G1
Bravenboer, B1
van Buren, T1
Traber, J1
de Wildt, DJ2
Gispen, WH2
Cammilleri, S1
Perdereau, B1
Brixy, F1
Pierga, JY1
Benyahia, B1
Chypre, C1
Magdelenat, H1
Vandertop, WP1
de Vries, WB1
Notermans, NC1
Nijsen, MJ1
Tulleken, CA1
Chang, WC1
Chen, CC1
Tseng, TH1
Huang, HP1
Hsu, JD1
Wang, CJ1
Acar, H1
Copeland, NG1
Gilbert, DJ1
Jenkins, NA1
Largaespada, DA1
Tribble, DL1
Krauss, RM1
Chu, BM1
Gong, EL1
Kullgren, BR1
Nagy, JO1
La Belle, M1
Carson, RP1
Appalsamy, M1
Diedrich, A1
Davis, TL1
Robertson, D1
Hirsh, J1
Heros, RC1
Zervas, NT1
Negoro, M1
Dill, RE1
Dorris, RL1
Phillips-Thonnard, I1
Pourrias, B1
Marie, C1
Young, A1
Levin, RJ1
Pals, DT1
Masucci, FD1
Denning, GS1
Sipos, F1
Fessler, DC1
Weinshilboum, RM1
Kvetnansky, R1
Axelrod, J1
Kopin, IJ1

Reviews

2 reviews available for tyramine and Disease Models, Animal

ArticleYear
Time flies like an arrow. Fruit flies like crack?
    The pharmacogenomics journal, 2001, Volume: 1, Issue:2

    Topics: Animals; Circadian Rhythm; Cocaine-Related Disorders; Disease Models, Animal; Drosophila melanogaste

2001
Cerebral vasospasm.
    Surgical neurology, 1976, Volume: 5, Issue:6

    Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Angiotensin II; Animals; Blood Platelets;

1976

Other Studies

40 other studies available for tyramine and Disease Models, Animal

ArticleYear
The Trace Amine 1 receptor knockout mouse: an animal model with relevance to schizophrenia.
    Genes, brain, and behavior, 2007, Volume: 6, Issue:7

    Topics: Amphetamine; Animals; Anxiety; Behavior, Animal; Catecholamines; Central Nervous System Stimulants;

2007
Inhibition of natriuretic peptide receptor 1 reduces itch in mice.
    Science translational medicine, 2019, 07-10, Volume: 11, Issue:500

    Topics: Animals; Behavior, Animal; Cell-Free System; Dermatitis, Contact; Disease Models, Animal; Ganglia, S

2019
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
    Proceedings of the National Academy of Sciences of the United States of America, 2020, 12-08, Volume: 117, Issue:49

    Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Dr

2020
GPR120 Inhibits Colitis Through Regulation of CD4
    Gastroenterology, 2022, Volume: 162, Issue:1

    Topics: Acetates; Adoptive Transfer; Animals; Anti-Inflammatory Agents, Non-Steroidal; Case-Control Studies;

2022
Beneficial Effects of Hordenine on a Model of Ulcerative Colitis.
    Molecules (Basel, Switzerland), 2023, Mar-21, Volume: 28, Issue:6

    Topics: Animals; Anti-Inflammatory Agents; Colitis; Colitis, Ulcerative; Colon; Dextran Sulfate; Disease Mod

2023
Intratumoral injection of anlotinib hydrogel enhances antitumor effects and reduces toxicity in mouse model of lung cancer.
    Drug delivery, 2020, Volume: 27, Issue:1

    Topics: Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Lewis Lung; Cell Line, Tumor; Cell Proliferati

2020
Riparin II potentials the effect of ephedrine on inflammation and remodelling in the airway of rats suffering from asthma by regulating transforming growth factor-β/Smad3 signalling pathway.
    International immunopharmacology, 2021, Volume: 90

    Topics: Airway Remodeling; Animals; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Benzamides; Col

2021
Is Riparin III a promising drug in the treatment for depression?
    European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2021, Jul-01, Volume: 162

    Topics: Animals; Behavior, Animal; Benzamides; Corticosterone; Depression; Disease Models, Animal; Female; M

2021
    Journal of applied social psychology, 2021, Volume: 51, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Animals; Anti-Bacterial Agents; Anti-

2021
Nonclinical Evaluation of Antibacterial Oxazolidinones Contezolid and Contezolid Acefosamil with Low Serotonergic Neurotoxicity.
    Chemical research in toxicology, 2021, 05-17, Volume: 34, Issue:5

    Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Blood Pressure; Disease Models, Animal; Dose-R

2021
Antinociceptive activity of Riparin II from Aniba riparia: Further elucidation of the possible mechanisms.
    Chemico-biological interactions, 2018, May-01, Volume: 287

    Topics: Acid Sensing Ion Channels; Alanine Transaminase; Analgesics; Animals; Aspartate Aminotransferases; B

2018
Riparin II ameliorates corticosterone-induced depressive-like behavior in mice: Role of antioxidant and neurotrophic mechanisms.
    Neurochemistry international, 2018, Volume: 120

    Topics: Animals; Antidepressive Agents; Antioxidants; Behavior, Animal; Benzamides; Brain-Derived Neurotroph

2018
Reversal effect of Riparin IV in depression and anxiety caused by corticosterone chronic administration in mice.
    Pharmacology, biochemistry, and behavior, 2019, Volume: 180

    Topics: Amides; Anhedonia; Animals; Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Behavior, Animal; B

2019
Selective modulation through the glucocorticoid receptor ameliorates muscle pathology in mdx mice.
    The Journal of pathology, 2013, Volume: 231, Issue:2

    Topics: Acetates; Animals; Blotting, Western; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Flo

2013
Evaluation of the anti-inflammatory activity of riparin II (O-methil-N-2-hidroxi-benzoyl tyramine) in animal models.
    Chemico-biological interactions, 2013, Oct-05, Volume: 205, Issue:3

    Topics: Animals; Anti-Inflammatory Agents; Benzamides; Disease Models, Animal; Edema; Inflammation; Male; Ma

2013
Effects of the selective glucocorticoid receptor modulator compound A on bone metabolism and inflammation in male mice with collagen-induced arthritis.
    Endocrinology, 2013, Volume: 154, Issue:10

    Topics: Acetates; Animals; Antirheumatic Agents; Arthritis, Rheumatoid; Biomarkers; Bone and Bones; Bone Den

2013
Hypoglycemic and hypotensive activity of a root extract of Smilax aristolochiifolia, standardized on N-trans-feruloyl-tyramine.
    Molecules (Basel, Switzerland), 2014, Jul-31, Volume: 19, Issue:8

    Topics: Animals; Antihypertensive Agents; Blood Pressure; Chromatography, High Pressure Liquid; Coumaric Aci

2014
Impaired heart rate regulation and depression of cardiac chronotropic and dromotropic function in polymicrobial sepsis.
    Shock (Augusta, Ga.), 2015, Volume: 43, Issue:2

    Topics: Adrenergic beta-Agonists; Adrenergic Uptake Inhibitors; Animals; Coinfection; Disease Models, Animal

2015
Antinociceptive effects of (O-methyl)-N-benzoyl tyramine (riparin I) from Aniba riparia (Nees) Mez (Lauraceae) in mice.
    Naunyn-Schmiedeberg's archives of pharmacology, 2009, Volume: 380, Issue:4

    Topics: Acetic Acid; Administration, Oral; Analgesics; Analgesics, Opioid; Animals; Arginine; Behavior, Anim

2009
Therapeutic and adverse effects of a non-steroidal glucocorticoid receptor ligand in a mouse model of multiple sclerosis.
    PloS one, 2009, Dec-07, Volume: 4, Issue:12

    Topics: Acetates; Animals; Apoptosis; Aziridines; Cell Adhesion Molecules; Disease Models, Animal; Dose-Resp

2009
Spontaneous atrial fibrillation initiated by tyramine in canine atria with increased sympathetic nerve sprouting.
    Journal of cardiovascular electrophysiology, 2012, Volume: 23, Issue:4

    Topics: Action Potentials; Animals; Atrial Appendage; Atrial Fibrillation; Atrial Function, Left; Calcium Si

2012
A dissociated glucocorticoid receptor modulator reduces airway hyperresponsiveness and inflammation in a mouse model of asthma.
    Journal of immunology (Baltimore, Md. : 1950), 2012, Apr-01, Volume: 188, Issue:7

    Topics: Acetates; Animals; Anti-Asthmatic Agents; Anti-Inflammatory Agents, Non-Steroidal; Asthma; Bronchial

2012
SL25.1131 [3(S),3a(S)-3-methoxymethyl-7-[4,4,4-trifluorobutoxy]-3,3a,4,5-tetrahydro-1,3-oxazolo[3,4-a]quinolin-1-one], a new, reversible, and mixed inhibitor of monoamine oxidase-A and monoamine oxidase-B: biochemical and behavioral profile.
    The Journal of pharmacology and experimental therapeutics, 2004, Volume: 310, Issue:3

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Benzophenones; Brain; Corpus Striatum; Disease Models, Anim

2004
Postinfarct sympathetic hyperactivity differentially stimulates expression of tyrosine hydroxylase and norepinephrine transporter.
    American journal of physiology. Heart and circulatory physiology, 2008, Volume: 294, Issue:1

    Topics: Adrenergic beta-Agonists; Angiotensinogen; Animals; Animals, Genetically Modified; Coronary Vessels;

2008
Effects of procainamide and N-acetylprocainamide on myocardial contractility in ischemic isolated rabbit hearts.
    Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.), 1981, Volume: 168, Issue:3

    Topics: Acecainide; Animals; Coronary Disease; Disease Models, Animal; Epinephrine; Male; Myocardial Contrac

1981
Similarity between tyramine-induced neurotoxicity and the coma of Reye's syndrome.
    The Journal of pharmacology and experimental therapeutics, 1983, Volume: 226, Issue:2

    Topics: Animals; Coma; Disease Models, Animal; Dogs; Intracranial Pressure; Kinetics; Liver; Liver Function

1983
[Effects of parasympathetic drugs on head-twitch response induced by tyramine (author's transl)].
    Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 1981, Volume: 77, Issue:5

    Topics: Animals; Dioxoles; Disease Models, Animal; Hallucinations; Head; Humans; Injections, Intraperitoneal

1981
Apolipoprotein AI levels are increased in part as a consequence of reduced catabolism in nephrotic rats.
    The American journal of physiology, 1995, Volume: 268, Issue:3 Pt 2

    Topics: Animals; Apolipoprotein A-I; Cellobiose; Cholesterol; Disease Models, Animal; Doxorubicin; Glomerulo

1995
Beneficial effect of the Ca2+ antagonist, nimodipine, on existing diabetic neuropathy in the BB/Wor rat.
    British journal of pharmacology, 1994, Volume: 111, Issue:3

    Topics: Animals; Autonomic Nervous System; Blood Glucose; Blood Pressure; Body Weight; Diabetic Neuropathies

1994
Imaging and biodistribution of 125I tyramine oligonucleotide in nude mice bearing human breast tumor. Preliminary report.
    Bulletin du cancer, 1996, Volume: 83, Issue:1

    Topics: Animals; Disease Models, Animal; Female; Iodine Radioisotopes; Mammary Neoplasms, Experimental; Mice

1996
Cisplatin-induced autonomic neuropathy: does it really exist?
    Journal of neuro-oncology, 1996, Volume: 27, Issue:1

    Topics: Analysis of Variance; Animals; Antineoplastic Agents; Autonomic Nervous System Diseases; Blood Press

1996
Tumor promotion of N-nitroso-N-(3-keto-1, 2-butanediol)-3'-nitrotyramine derived from nitrosation of Maillard reaction product in CD-1 mice.
    Toxicology and applied pharmacology, 2000, Jul-01, Volume: 166, Issue:1

    Topics: Animals; Carcinogens; Disease Models, Animal; Edema; Enzyme Activation; Female; Hydrogen Peroxide; H

2000
Detection of integrated murine leukemia viruses in a mouse model of acute myeloid leukemia by fluorescence in situ hybridization combined with tyramide signal amplification.
    Cancer genetics and cytogenetics, 2000, Volume: 121, Issue:1

    Topics: Acute Disease; Animals; Chromosome Mapping; Crosses, Genetic; Disease Models, Animal; DNA Probes; DN

2000
Increased low density lipoprotein degradation in aorta of irradiated mice is inhibited by preenrichment of low density lipoprotein with alpha-tocopherol.
    Journal of lipid research, 2000, Volume: 41, Issue:10

    Topics: Animals; Aorta; Arteriosclerosis; Cellobiose; Disease Models, Animal; Free Radical Scavengers; Human

2000
Animal model of neuropathic tachycardia syndrome.
    Hypertension (Dallas, Tex. : 1979), 2001, Volume: 37, Issue:6

    Topics: Adrenergic Agents; Animals; Autonomic Nervous System Diseases; Blood Pressure; Disease Models, Anima

2001
A pharmacologic model of Huntington's chorea.
    The Journal of pharmacy and pharmacology, 1976, Volume: 28, Issue:8

    Topics: Animals; Carbachol; Catheterization; Clozapine; Corpus Striatum; Disease Models, Animal; Dyskinesia,

1976
Effects of tilting in the anaesthetized and mechanically ventilated rat: a model of orthostatic hypotension.
    Fundamental & clinical pharmacology, 1992, Volume: 6, Issue:1

    Topics: Anesthesia; Animals; Blood Pressure; Catecholamines; Disease Models, Animal; Heart Rate; Hypotension

1992
Diarrhoea of famine and malnutrition: investigations using a rat model. 1. Jejunal hypersecretion induced by starvation.
    Gut, 1990, Volume: 31, Issue:1

    Topics: Animals; Bethanechol; Bethanechol Compounds; Carbachol; Chlorides; Diarrhea; Disease Models, Animal;

1990
Role of the pressor action of angiotensin II in experimental hypertension.
    Circulation research, 1971, Volume: 29, Issue:6

    Topics: Angiotensin II; Animals; Aorta, Thoracic; Culture Techniques; Desoxycorticosterone; Disease Models,

1971
Elevation of serum dopamine-beta-hydroxylase activity with forced immobilization.
    Nature: New biology, 1971, Apr-28, Volume: 230, Issue:17

    Topics: Adrenal Medulla; Adrenalectomy; Animals; Carbon Isotopes; Disease Models, Animal; Dopamine; Immobili

1971